Literature DB >> 34993103

Semi-automatic quantitative analysis of the pelvic bony structures on apparent diffusion coefficient maps based on deep learning: establishment of reference ranges.

Xiang Liu1, Chao Han1, Ziying Lin1, Zhaonan Sun1, Yaofeng Zhang2, Xiangpeng Wang2, Xiaodong Zhang1, Xiaoying Wang1.   

Abstract

BACKGROUND: Apparent diffusion coefficient (ADC) maps provide quantitative information on both normal and abnormal tissues. However, it is difficult to distinguish between these tissues unless consistent and precise ADC values can be obtained from normal tissues. For this study we developed a deep learning-based convolutional neural network (CNN) for pelvic bony structure segmentation and established the reference ranges of ADC parameters for normal pelvic bony structures.
METHODS: We retrospectively enrolled 767 prostate cancer (PCa) patients for quantitative ADC analyses of normal pelvic bony structures. A subset of 288 patients who did not receive treatment for PCa (S1) were used to develop a CNN model for the segmentation of 8 pelvic bony structures (lumbar vertebra, sacrococcyx, ilium, acetabulum, femoral head, femoral neck, ischium, and pubis). The proposed CNN was used for the automated segmentation of these pelvic bony structures from a subset of 405 patients who did not receive treatment (S2) and 74 patients who received treatment [radiotherapy (S3) or endocrine therapy (S4)]. The 95% confidence interval (CI) was used to establish reference ranges for the ADC values from the normal pelvic bony structures of S1 and S2.
RESULTS: The Dice scores (Sørensen-Dice coefficient) for the CNN segmentation of the 8 pelvic bones on the ADC maps ranged from 0.90±0.02 (ilium) to 0.95±0.03 (femoral head) in the S1 testing set. In the S2 data set, the Dice scores showed no significant difference among the different scanners (P>0.05), and no significant differences were found among the S2, S3, and S4 data sets. The correlation analysis revealed that the b value and field strength were significantly correlated with ADC values (all P<0.001), while age and treatment were not significant variables (all P>0.05). The ADC reference ranges (95% CI) were as follows: lumbar vertebra, 1.11 (0.90-1.54); sacrococcyx, 0.82 (0.61-1.15); ilium, 0.57 (0.45-0.62); acetabulum, 0.59 (0.40-0.69); femoral head, 0.46 (0.25-0.58); femoral neck, 0.43 (0.25-0.48); ischium, 0.45 (0.26-0.55); and pubis, 0.57 (0.45-0.65).
CONCLUSIONS: This study preliminarily established reference ranges for the ADC values of normal pelvic bony structures. The image acquisition parameters had an influence on the ADC values. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Quantitative evaluation; apparent diffusion coefficient maps (ADC maps); convolutional neural network (CNN); pelvic bones; reference range

Year:  2022        PMID: 34993103      PMCID: PMC8666747          DOI: 10.21037/qims-21-123

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  31 in total

1.  Analysis of diffusion changes in posttraumatic bone marrow using navigator-corrected diffusion gradients.

Authors:  R Ward; S Caruthers; C Yablon; M Blake; M DiMasi; S Eustace
Journal:  AJR Am J Roentgenol       Date:  2000-03       Impact factor: 3.959

2.  Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility.

Authors:  C Messiou; D J Collins; V A Morgan; N M Desouza
Journal:  Eur Radiol       Date:  2011-04-07       Impact factor: 5.315

Review 3.  Deep learning.

Authors:  Yann LeCun; Yoshua Bengio; Geoffrey Hinton
Journal:  Nature       Date:  2015-05-28       Impact factor: 49.962

4.  Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.

Authors:  Raquel Perez-Lopez; Joaquin Mateo; Helen Mossop; Matthew D Blackledge; David J Collins; Mihaela Rata; Veronica A Morgan; Alison Macdonald; Shahneen Sandhu; David Lorente; Pasquale Rescigno; Zafeiris Zafeiriou; Diletta Bianchini; Nuria Porta; Emma Hall; Martin O Leach; Johann S de Bono; Dow-Mu Koh; Nina Tunariu
Journal:  Radiology       Date:  2016-11-22       Impact factor: 11.105

5.  Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.

Authors:  Riham H Ei Khouli; Michael A Jacobs; Sarah D Mezban; Peng Huang; Ihab R Kamel; Katarzyna J Macura; David A Bluemke
Journal:  Radiology       Date:  2010-07       Impact factor: 11.105

Review 6.  Metastasis Reporting and Data System for Prostate Cancer in Practice.

Authors:  Anwar R Padhani; Nina Tunariu
Journal:  Magn Reson Imaging Clin N Am       Date:  2018-11       Impact factor: 2.266

7.  Time trends and local variation in primary treatment of localized prostate cancer.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

8.  Apparent Diffusion Coefficient of Normal Abdominal Organs and Bone Marrow From Whole-Body DWI at 1.5 T: The Effect of Sex and Age.

Authors:  Ioannis Lavdas; Andrea G Rockall; Federica Castelli; Ranbir S Sandhu; Annie Papadaki; Lesley Honeyfield; Adam D Waldman; Eric O Aboagye
Journal:  AJR Am J Roentgenol       Date:  2015-08       Impact factor: 3.959

9.  Automated CT and MRI Liver Segmentation and Biometry Using a Generalized Convolutional Neural Network.

Authors:  Kang Wang; Adrija Mamidipalli; Tara Retson; Naeim Bahrami; Kyle Hasenstab; Kevin Blansit; Emily Bass; Timoteo Delgado; Guilherme Cunha; Michael S Middleton; Rohit Loomba; Brent A Neuschwander-Tetri; Claude B Sirlin; Albert Hsiao
Journal:  Radiol Artif Intell       Date:  2019-03-27

10.  Predicting clinically significant prostate cancer from quantitative image features including compressed sensing radial MRI of prostate perfusion using machine learning: comparison with PI-RADS v2 assessment scores.

Authors:  David Jean Winkel; Hanns-Christian Breit; Bibo Shi; Daniel T Boll; Hans-Helge Seifert; Christian Wetterauer
Journal:  Quant Imaging Med Surg       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.